Physician profile
Jessica Vaught
NPI 1033164231
$129,455.55
in general payments reported to CMS, 2019-2025
26 companies · $8,328 in 2025
The $8,328 reported for 2025 was more than what 95% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $6,027 · 2021: $15K · 2022: $38K · 2023: $24K · 2024: $13K · 2025: $8,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $36K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Food and Beverage: $1,533 · Travel and Lodging: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $35,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Food and Beverage | $1,532.63 |
| Travel and Lodging | $996.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $126,383.53 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Conmed Corporation | $1,466.50 | 2021 | |
| Abbvie INC. | $331.29 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $199.48 | 2022-2024 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $194.85 | 2022-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Becton, Dickinson and Company | $102.40 | 2019-2022 | |
| Gauss Surgical INC. | $97.91 | 2019 | |
| Sumitomo Pharma America, INC. | $89.29 | 2023-2025 | Myfembree |
| Baxter Healthcare | $73.24 | 2023 | Tisseel |
| Hologic Sales and Service, LLC | $67.65 | 2020-2025 | Myosure Tissue Removal Device, Novasure |
| Pfizer INC. | $62.54 | 2022-2024 | |
| Millicent US INC | $60.00 | 2023-2025 | Intrarosa, Femring |
| Daiichi Sankyo INC. | $49.57 | 2022-2024 | Injectafer |
| Aspira Women'S Health INC | $38.16 | 2022 | |
| Medical Device Business Services, INC. | $26.61 | 2025 | Ethicon |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $25.42 | 2025 | |
| Davol INC. | $24.65 | 2024 | Arista Ah Flexitip |
| Monaghan Medical Corporation | $23.62 | 2023 | Aerochamber |
| Convatec INC. | $21.47 | 2022 | |
| Myovant Sciences INC. | $19.99 | 2022 | |
| Dysis Medical, INC. | $18.82 | 2019 | |
| Organon LLC | $18.33 | 2022 | |
| Sage Therapeutics, LLC | $15.76 | 2022 | |
| Gynesonics, INC. | $15.70 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medtronic, INC. | $14.64 | 2021 | |
| Merck Sharp & Dohme LLC | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Vaught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.